RETRACTED: A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
2021 · Frontiers in Oncology · 19 citations
https://doi.org/10.3389/fonc.2020.565384
J
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
138
Citations
7
h-index
5
i10-index
Jiayu Wang is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology & Advanced Breast Cancer Therapies. The author has an h-index of 7, co-authored 18 publications.
ORCID: 0000-0001-5673-7640Papers by this author
worksProfile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study
2020 · International Journal of Cancer · 17 citations
https://doi.org/10.1002/ijc.33227
Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice
2020 · Clinical Breast Cancer · 7 citations
https://doi.org/10.1016/j.clbc.2020.09.003
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy
2021 · BMC Cancer · 4 citations
https://doi.org/10.1186/s12885-021-08093-z
Cardamom synergizes with cisplatin against human osteosarcoma cells by mTOR-mediated autophagy
2025 · Cancer Gene Therapy · 0 citations
https://doi.org/10.1038/s41417-025-00894-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat